We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $3.09B
1-Year Est. Return 31.21%
This Fund
S&P 500
This Quarter Est. Return
+16.6%
1 Year Est. Return
+31.21%
3 Year Est. Return
+54.52%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.37%
AUM
$2.3B
AUM Growth
-$158M
Cap. Flow
-$1.36B
Cap. Flow %
-59.29%
Top 10 Hldgs %
37.61%
Holding
364
New
63
Increased
22
Reduced
27
Closed
57

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$79M
2
ALE
Allete
ALE
+$57.5M
3
AMED
Amedisys
AMED
+$33.3M
4
SKX
Skechers
SKX
+$25.2M
5
BPMC
Blueprint Medicines
BPMC
+$24.3M

Sector Composition

Rank Sector Weight
1 Communication Services 8.64%
2 Financials 3.1%
3 Healthcare 2.77%
4 Technology 2.29%
5 Consumer Staples 1.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LITE icon
51
Lumentum
LITE
$64.3B
$3.08M 0.13%
+18,900
New +$2.36M
BCSS.U
52
Bain Capital GSS Investment Corp Units
BCSS.U
$3.03M 0.13%
+300,000
New +$3.03M
BRKRP
53
Bruker Corporation 6.375% Series A Preferred Stock
BRKRP
$1.08B
$2.72M 0.12%
+10,000
New +$2.67M
DRDB
54
Roman DBDR Acquisition Corp II
DRDB
$325M
$2.58M 0.11%
250,000
BXBL
55
BOXABL, Inc. Common stock
BXBL
$1.57B
$2.54M 0.11%
254,607
+157,902
+163% +$1.57M
AMPX.WS icon
56
Amprius Technologies Warrants
AMPX.WS
$580M
0
AEXA
57
American Exceptionalism Acquisition Corp
AEXA
$570M
$2.32M 0.1%
+212,500
New +$2.29M
EMISU
58
DELISTED
Emmis Acquisition Corp Units
EMISU
$2.2M 0.1%
+220,000
New +$2.2M
WOLF icon
59
PUT
Wolfspeed
WOLF
$1.31B
$1.85M 0.08%
+64,557
New +$151K
OKUR
60
OnKure Therapeutics
OKUR
$168M
$1.79M 0.08%
650,218
-13,389
-2% -$33.2K
KW
61
DELISTED
Kennedy-Wilson Holdings
KW
$1.55M 0.07%
186,608
-23,392
-11% -$188K
PI icon
62
Impinj
PI
$4.99B
$1.45M 0.06%
+8,001
New +$1.26M
OSCR icon
63
Oscar Health
OSCR
$9.08B
$1.31M 0.06%
+69,100
New +$1.14M
SM icon
64
SM Energy
SM
$6.96B
$1.25M 0.05%
50,000
GTEN
65
Gores Holdings X
GTEN
$473M
$1.02M 0.04%
100,000
EA icon
66
Electronic Arts
EA
$52.9B
$1.01M 0.04%
+5,000
New +$828K
GLIBA
67
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$965M
$997K 0.04%
+26,541
New +$943K
LZM.WS icon
68
Lifezone Metals Ltd Warrants
LZM.WS
$29.3M
0
IRWD icon
69
Ironwood Pharmaceuticals
IRWD
$683M
$704K 0.03%
+537,252
New +$556K
ESPR
70
DELISTED
Esperion Therapeutics
ESPR
$674K 0.03%
254,265
KDKRW
71
Kodiak AI Warrants
KDKRW
0
NSC icon
72
Norfolk Southern
NSC
$76.8B
$601K 0.03%
+2,000
New +$556K
VCICW
73
DELISTED
Vine Hill Capital Investment Corp Warrant
VCICW
0
OTGAU
74
OTG Acquisition Corp I Unit
OTGAU
$214M
$554K 0.02%
+54,986
New +$552K
AFRIW icon
75
Forafric Global PLC Warrants
AFRIW
$9.67M
0

Similar funds

Highbridge Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Highbridge Capital Management held 364 positions worth $2.3B, down 6.4% from $2.45B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Highbridge Capital Management withdrew a net $1.36B in Q3 2025, closing 57 positions and reducing 27 holdings. Its most notable exit was Hess, an estimated $79M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 8.6% of assets, up from 6.8% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Highbridge Capital Management opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $103M.

  • Highbridge Capital Management's largest Q3 2025 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,274,752 shares worth $103M.
  • Highbridge Capital Management added most to TXNM Energy Inc in Q3 2025, an estimated $35.1M increase.
  • Highbridge Capital Management's biggest Q3 2025 reduction was HEICO Corp Class A, cutting an estimated $20.8M.
  • Highbridge Capital Management fully exited Hess in Q3 2025, selling an estimated $79M.
  • Highbridge Capital Management's ten largest holdings make up 38% of its $2.3B portfolio in Q3 2025.
  • Highbridge Capital Management opened 63 new positions and closed 57 in Q3 2025.
  • Highbridge Capital Management's portfolio value fell 6.4% quarter-over-quarter to $2.3B.

Based on Highbridge Capital Management's 13F filing for Q3 2025, filed 10 Nov 2025.